Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cystatin C-guided vs Creatinine-guided Vancomycin Dosing in Critically Ill Adults
NCT02945241Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- Jun 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
Phase 1, open-label trial of vancomycin in Gram-positive bacterial infection (2 arms), sponsored by Mayo Clinic. Primary endpoint: Vancomycin target trough achievement. Started Apr 2014; status: completed.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT02945241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945241.